Provide Your Input: Ministry of Health is Considering the Following Drugs for Pharmacare Coverage

The Ministry of Health is considering the following drugs for PharmaCare coverage:

 Generic name: relugolix, estradiol, and norethindrone acetate

Brand name: Myfembree®

Drug used for: Heavy menstrual bleeding associated with uterine fibroids in premenopausal women

Input accepted: From Wednesday, May 28, 2025, to Tuesday, June 24, 2025 

AT 11:59 PM

Generic name: guselkumab

Brand name: Tremfya®

Drug used for: Moderately to severely active Crohn’s disease in adults

Input accepted: From Wednesday, May 28, 2025, to Tuesday, June 24, 2025 

AT 11:59 PM

To provide input, please visit our website at http://www.gov.bc.ca/bcyourvoice.

IMPORTANT: The Ministry of Health must receive input for the drugs listed above no later than 11:59 PM ON Tuesday, June 24, 2025.